Development of an Individualized Immune Prognostic Signature for Clear Cell Renal Cell Carcinoma through the Identification of Differential Immune Genes

Figure 2

Differences in the tumor microenvironments between the high- and low-immunity groups. (a) Differences in the 22 tumor-infiltrating immune cells between the high- and low-immunity groups. Blue represents the low-immunity group, and red represents the high-immunity group. Correlations between the immune cells in the (b) low-immunity and (c) high-immunity groups.

(a)

(b)

(c)